Finance

Beta
Lists
IGC:NYSEAMERICAN
IGC Pharma Inc
$0.30
+3.45%
(+0.010) 1D
$0.30
+1.67% (+0.0050)
After hours
Closed: Jun 3, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IGC...
Open
$0.28
High
$0.31
Low
$0.28
Mkt. cap
30.03M
Avg. vol.
796.45K
Volume
144.00
52-wk high
$0.50
52-wk low
$0.24
EPS
-$0.07
Beta
0.46
Shares outstanding
100.09M
No. of employees
70
Open
$0.28
High
$0.31
Low
$0.28
Mkt. cap
30.03M
Avg. vol.
796.45K
Volume
144.00
52-wk high
$0.50
52-wk low
$0.24
EPS
-$0.07
Beta
0.46
Shares outstanding
100.09M
No. of employees
70
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to IGC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for IGC in the last 3 months.
Highest
Current $0.30
$5.25 (+1,650.00%)
Average
$5.25 (+1,650.00%)
Lowest
$5.25 (+1,650.00%)
News stories
From sources across the web
About IGC Pharma Inc
CEO-
Employees70
Founded2005
HeadquartersPotomac, Maryland, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Sep 2025
Mar 2026
Revenue
257.00K
330.00K
191.00K
317.00K
Cost of goods sold
153.00K
176.00K
92.00K
174.00K
Cost of revenue
153.00K
176.00K
92.00K
262.00K
Research and development expenses
852.00K
997.00K
1.59M
1.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.13M
619.00K
1.41M
1.20M
Operating expense
1.98M
1.62M
3.00M
2.51M
Total operating expenses
2.14M
1.79M
3.09M
2.78M
Operating income
-1.88M
-1.46M
-2.90M
-2.46M
Other non operating income
49.00K
190.00K
1.08M
56.00K
EBT including unusual items
-1.83M
-1.20M
-1.82M
-1.60M
EBT excluding unusual items
-1.83M
-1.27M
-1.82M
-1.60M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.83M
-1.20M
-1.82M
-2.40M
Net profit margin
-711.67%
-362.73%
-953.40%
-757.73%
Earnings per share
-0.02
-0.01
-0.02
-0.02
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.72M
-1.31M
-2.78M
-2.40M
Gain or loss from assets sale
-
-25.00K
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more